MATTHEW W FOEHR Insider Trading $LGND LIGAND PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MATTHEW W FOEHR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW W FOEHR. MATTHEW W FOEHR is EVP and COO in LIGAND PHARMACEUTICALS INC ($LGND).
MATTHEW W FOEHR in LIGAND PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: EVP and COO
Holdings: 68,128 shares
Current Value: $7,346,924
Latest Transaction: Feb 11 2015
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MATTHEW W FOEHR in LIGAND PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2015 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 56.26 | 42,113 | 2,369,277 | 42,113 | |
| Feb 11 2015 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Grant | A | 0.00 | 13,112 | 0 | 68,128 | 55 K to 68.1 K (+23.83 %) |
| Jan 05 2015 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | P | 45.23 | 46 | 2,081 | 55,016 | 55 K to 55 K (+0.08 %) |
| Oct 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | M | 9.97 | 1,000 | 9,970 | 132,056 | |
| Oct 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | M | 9.97 | 1,000 | 9,970 | 54,970 | 54 K to 55 K (+1.85 %) |
| Oct 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | P | 44.91 | 85 | 3,817 | 53,970 | 53.9 K to 54 K (+0.16 %) |
| Jul 01 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | P | 43.79 | 428 | 18,743 | 53,885 | 53.5 K to 53.9 K (+0.80 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 74.42 | 10,000 | 744,200 | 65,000 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 74.42 | 10,000 | 744,200 | 55,000 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 74.42 | 45,000 | 3,348,900 | 45,000 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | M | 9.97 | 22,500 | 224,325 | 133,056 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | M | 9.97 | 3,444 | 34,337 | 155,556 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Sell | S | 79.54 | 22,500 | 1,789,650 | 53,457 | 76 K to 53.5 K (-29.62 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | M | 9.97 | 22,500 | 224,325 | 75,957 | 53.5 K to 76 K (+42.09 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | M | 9.97 | 3,444 | 34,337 | 53,457 | 50 K to 53.5 K (+6.89 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Grant | A | 0.00 | 5,000 | 0 | 50,013 | 45 K to 50 K (+11.11 %) |
| Jan 02 2014 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | P | 33.92 | 84 | 2,849 | 45,013 | 44.9 K to 45 K (+0.19 %) |
| Dec 13 2013 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | M | 9.97 | 6,000 | 59,820 | 159,000 | |
| Dec 13 2013 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Sell | S | 53.40 | 6,000 | 320,400 | 44,929 | 50.9 K to 44.9 K (-11.78 %) |
| Dec 13 2013 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | M | 9.97 | 6,000 | 59,820 | 50,929 | 44.9 K to 50.9 K (+13.35 %) |
| Jul 01 2013 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | P | 17.36 | 1,059 | 18,384 | 44,929 | 43.9 K to 44.9 K (+2.41 %) |
| Feb 19 2013 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 21.92 | 64,625 | 1,416,580 | 64,625 | |
| Feb 19 2013 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 21.92 | 8,375 | 183,580 | 8,375 | |
| Feb 19 2013 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Grant | A | 0.00 | 6,000 | 0 | 43,870 | 37.9 K to 43.9 K (+15.84 %) |
| Dec 05 2012 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | P | 17.99 | 370 | 6,656 | 37,870 | 37.5 K to 37.9 K (+0.99 %) |
| Jul 03 2012 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | J | 10.12 | 1,250 | 12,654 | 37,500 | 36.3 K to 37.5 K (+3.45 %) |
Page: 1